SOBRsafe (NASDAQ: SOBR) has entered into definitive agreements for the immediate exercise of certain outstanding warrants at a reduced exercise price of $1.05 per share, generating expected gross proceeds of approximately $3.1 million before fees and expenses. The company will issue new unregistered Series E and Series F warrants to purchase an aggregate of 4.7 million shares in connection with the transaction. The offering is expected to close on or about July 16, 2026, with net proceeds designated for working capital and general corporate purposes. H.C. Wainwright & Co. is serving as the exclusive placement agent. For the full press release, visit https://nnw.fm/jzJjF.
SOBRsafe's advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin – no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides passive, dignified screening and monitoring solutions for the behavioral health, family law and consumer markets, and for licensing and integration. The company's technology enables trust and empowers recovery with a human touch. More information is available at www.sobrsafe.com.
This capital raise is significant for SOBRsafe as it provides additional working capital to support the company's operations and growth initiatives. The exercise of warrants at a reduced price indicates that existing warrant holders see value in the company's prospects, potentially signaling confidence in SOBRsafe's technology and market position. The issuance of new warrants could also provide a future capital source if exercised.
The transaction underscores SOBRsafe's efforts to strengthen its financial position amid the growing demand for non-invasive alcohol detection solutions. The company's touch-based technology offers a discreet and convenient alternative to traditional breathalyzers or blood tests, appealing to various sectors including behavioral health, family law, and consumer markets. By securing this funding, SOBRsafe is better positioned to expand its market reach and invest in product development.
Investors and stakeholders should monitor how SOBRsafe utilizes these proceeds to drive growth and enhance shareholder value. The company's ability to execute on its business plan will be crucial in the competitive landscape of alcohol detection technology. For ongoing updates, visit the company's newsroom at https://nnw.fm/SOBR.
